Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
eNq1mFFv2jAQx9/5FFHeSUgpo50C1cbKhtSqjBZt2gsyyVHMgp2ebaD79HMI3WBy1NXgx/icv8++8+9Ojq82y8xbAQrKWcePgobvAUt4Stljxx8/9OsX/lW3Fi/IiuxNaweNIDrzvSQjQnT8whpMgTARfL+9+QT6f0C/W/NiPl1AIg/mKUmz4AsR81uSF3O8eMVp6i1Bznna8XMlt6NeLCRqL7prjj9FThKIw93IvnUxOd8fj8NC7D9UlQC8IezRKArMSjNRiMBkj0h45Phc4W/TSpuKEQiuMIEhkfMh8hVNITUuMSOZAKtFZuv0HnCVgSwWMYqHi2QprMTJgmxG8DQwO/1BW3tyI+uNetRuty6azUYrujy3Cy7uHZU5CnoTYTKJmq3LdrMRAtPK2qKDZxmcIUdJMkdhoaJ3mFmO1kF4ejX8KRV5Rp6Dhchtj4og0WZAff/dbaTYwQNqImX6zP7RZyrLwjd6Pd7xwpHHBY56XDFZgY3+yPYgepxJ2FRH1I50crPLRQridLK/ODNTfqimGU1smaapo0DI8WhQjbST0uAjETBGdzj4RlnK1+L0mNkPqyPv8y0pjaI5ptHk7PLiXdRqWd+iHzqHKmrMtUKeQ6gBRMUxXBmwGT+WKDotzVIvSXm6fNy2OjwhGVQ0O3VLuuhEfOnNnKW6u2tUGoyin68fbPPjqwJ8vt9+GqVp2vkTWTv0uuC5zsZKx9+e2+UVd9IGKzSjYy5lLt6H4Xq9DuZE1AXRpxTM8PRs36un7rpwJ0W7bGJKPjpyfVoWvreFyPaqvVbWj21Vd//vWmLjGhIVHBGLksrO2Dm4Pj2O//apztweHuDD3TLbnpJIypmrVkdNjYrHFQAdV9ZHDYi72YxWvIpU5mUcli8y3VocFq8x3dpvwAvm4w==
6NWwzcTAgZeC2k0z
